Publications by authors named "Oxana Ibraghimov-Beskrovnaya"

Claim this Profile
F
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models.
Timothy Weeden, Tyler Picariello, Brendan Quinn, Sean Spring, Pei-Yi Shen, Oxana Ibraghimov-Beskrovnaya

Commun Med (Lond)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro.
Agnes Cheong, Florin Craciun, Hervé Husson, Joseph Gans, Javier Escobedo, Oxana Ibraghimov-Beskrovnaya

Commun Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced exon skipping and prolonged dystrophin restoration achieved by TfR1-targeted delivery of antisense oligonucleotide using FORCE conjugation in mdx mice.
Cody A Desjardins, Monica Yao, John Hall, Emma O'Donnell, Reshmii Venkatesan, Oxana Ibraghimov-Beskrovnaya

Nucleic Acids Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease.
Gabriel C Baccam, Jian Xie, Xin Jin, Hyejung Park, Bing Wang, Oxana Ibraghimov-Beskrovnaya

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.
Diana Rubel, Joseph Boulanger, Florin Craciun, Ethan Y Xu, Yanqin Zhang, Oxana Ibraghimov-Beskrovnaya

Cells· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of TGF-β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta.
Benjamin Greene, Ryan J Russo, Shannon Dwyer, Katie Malley, Errin Roberts, Oxana Ibraghimov-Beskrovnaya

JBMR Plus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of cilia structure and function alleviates multi-organ pathology in Bardet-Biedl syndrome mice.
Hervé Husson, Nikolay O Bukanov, Sarah Moreno, Mandy M Smith, Brenda Richards, Oxana Ibraghimov-Beskrovnaya

Hum Mol Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosphingolipid metabolism and polycystic kidney disease.
Thomas A Natoli, Vijay Modur, Oxana Ibraghimov-Beskrovnaya

Cell Signal· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome.
Jifan Guo, Wenping Song, Joseph Boulanger, Ethan Y Xu, Fang Wang, Oxana Ibraghimov-Beskrovnaya

Hum Gene Ther· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.
Katy Billot, Charlène Coquil, Benoit Villiers, Béatrice Josselin-Foll, Nathalie Desban, Oxana Ibraghimov-Beskrovnaya

Am J Physiol Renal Physiol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of nephronophthisis.
Christina Bracken, Philippe Beauverger, Olivier Duclos, Ryan J Russo, Kelly A Rogers, Oxana Ibraghimov-Beskrovnaya

Am J Physiol Renal Physiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
Kelly A Rogers, Sarah E Moreno, Laurie A Smith, Hervé Husson, Nikolay O Bukanov, Oxana Ibraghimov-Beskrovnaya

Physiol Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.
Hervé Husson, Sarah Moreno, Laurie A Smith, Mandy M Smith, Ryan J Russo, Oxana Ibraghimov-Beskrovnaya

Hum Mol Genet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD.
Nikolay O Bukanov, Sarah E Moreno, Thomas A Natoli, Kelly A Rogers, Laurie A Smith, Oxana Ibraghimov-Beskrovnaya

Cell Cycle· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease.
Thomas A Natoli, Hervé Husson, Kelly A Rogers, Laurie A Smith, Bing Wang, Oxana Ibraghimov-Beskrovnaya

Hum Mol Genet· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.
Moumita Chaki, Rannar Airik, Amiya K Ghosh, Rachel H Giles, Rui Chen, Oxana Ibraghimov-Beskrovnaya

Cell· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR signaling in polycystic kidney disease.
Oxana Ibraghimov-Beskrovnaya, Thomas A Natoli

Trends Mol Med· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models.
Thomas A Natoli, Laurie A Smith, Kelly A Rogers, Bing Wang, Svetlana Komarnitsky, Oxana Ibraghimov-Beskrovnaya

Nat Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and urinary biomarker signatures for rapid preclinical in vivo assessment of CDK inhibition as a therapeutic approach for PKD.
Sarah Moreno, Oxana Ibraghimov-Beskrovnaya, Nikolay O Bukanov

Cell Cycle· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.
Thomas A Natoli, Tiffany C Gareski, William R Dackowski, Laurie Smith, Nikolay O Bukanov, Oxana Ibraghimov-Beskrovnaya

Am J Physiol Renal Physiol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular pathogenesis of ADPKD and development of targeted therapeutic options.
Oxana Ibraghimov-Beskrovnaya

Nephrol Dial Transplant· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting dysregulated cell cycle and apoptosis for polycystic kidney disease therapy.
Oxana Ibraghimov-Beskrovnaya

Cell Cycle· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.
Nikolay O Bukanov, Laurie A Smith, Katherine W Klinger, Steven R Ledbetter, Oxana Ibraghimov-Beskrovnaya

Nature· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.
Laurie A Smith, Nikolay O Bukanov, Hervé Husson, Ryan J Russo, Tiffany C Barry, Oxana Ibraghimov-Beskrovnaya

J Am Soc Nephrol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro cystogenesis: the search for drugs antagonizing cyst development.
Oxana Ibraghimov-Beskrovnaya, Nikolay O Bukanov

Nephrol Ther· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis